While GLP-1s offer a promising solution for weight loss, they come at a staggering cost
However, results from insulin sensitivity were contradictory [31, 32]
4 Accordingly, the manufacturer prescribing information for all currently available GLP-1 RAs includes a warning for increased risk of hypoglycemia when used in combination with an insulin secretagogue or insulin 5-11 and state that reducing the dose of the insulin secretagogue or insulin may be necessary to prevent hypoglycemia
A whole branch of science (Venomics!!) is dedicated to researching venom, often in the hopes of isolating and synthesizing useful components
Regular Check-ups and Dosage Adjustments It is recommended to have regular check-ups with your healthcare provider every three to six months while using Trulicity
Zhao, W., Devamanoharan, P